var data={"title":"Peliosis hepatis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Peliosis hepatis</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/contributors\" class=\"contributor contributor_credentials\">Wissam Bleibel, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/contributors\" class=\"contributor contributor_credentials\">Michael P Curry, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/contributors\" class=\"contributor contributor_credentials\">Sanjiv Chopra, MD, MACP</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/contributors\" class=\"contributor contributor_credentials\">Kristen M Robson, MD, MBA, FACG</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jun 27, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Peliosis hepatis is a rare vascular condition of the liver characterized by a proliferation of the sinusoidal hepatic capillaries that results in cystic blood-filled cavities distributed randomly throughout the liver [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/1,2\" class=\"abstract_t\">1,2</a>]. The term originates from the Greek &quot;pelios,&quot; which means <span class=\"nowrap\">blue/black</span> or discolored extravasated blood [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/3\" class=\"abstract_t\">3</a>]. Peliosis is most commonly found in the liver but can also involve the spleen, bone marrow, lungs, abdominal lymph nodes, and other organs [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/2,4\" class=\"abstract_t\">2,4</a>].</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The epidemiology of peliosis hepatis is incompletely understood since many patients are asymptomatic and remain undiagnosed. Peliosis hepatis is often an incidental finding on abdominal imaging or autopsy. The incidence does not differ by gender [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/5\" class=\"abstract_t\">5</a>].</p><p>The reported prevalence of peliosis hepatis in patients with associated conditions ranges from 0.2 percent of patients with pulmonary tuberculosis to as high as 22 percent in patients following renal transplant [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/2,6,7\" class=\"abstract_t\">2,6,7</a>]. </p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">ETIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>First described in patients with advanced cancer and tuberculosis and in users of anabolic steroids [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/2,8,9\" class=\"abstract_t\">2,8,9</a>], peliosis hepatis is now associated with a variety of conditions (<a href=\"image.htm?imageKey=GAST%2F66092\" class=\"graphic graphic_table graphicRef66092 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/10-13\" class=\"abstract_t\">10-13</a>]. The mechanisms by which these lead to peliosis hepatis is unknown. Risk factors can be divided into three categories:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Drug&ndash;related factors (ie, steroids, oral contraceptives, <a href=\"topic.htm?path=azathioprine-drug-information\" class=\"drug drug_general\">azathioprine</a>, chemotherapeutic agents).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Immune disorders (ie, diseases associated with secondary immunodeficiency such as hematologic disorders or immunosuppression following transplantation) [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/10,14\" class=\"abstract_t\">10,14</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Infectious causes (ie, tuberculosis, HIV, syphilis and <em>Bartonella henselae) </em>[<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/15-17\" class=\"abstract_t\">15-17</a>]. Bartonella-associated or bacillary peliosis hepatis is described separately. (See <a href=\"topic.htm?path=epidemiology-and-clinical-manifestations-of-bartonella-infections-in-hiv-infected-patients\" class=\"medical medical_review\">&quot;Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients&quot;</a>.)</p><p/><p>In the renal transplant setting, peliosis hepatis appears to be acquired after transplantation, rather than as a manifestation of chronic kidney disease [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/3,7,18\" class=\"abstract_t\">3,7,18</a>]. In one report, 22 percent of renal transplant recipients had peliosis hepatis compared with only 2 percent of those awaiting transplant [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/7\" class=\"abstract_t\">7</a>]. Possible explanations include use of <a href=\"topic.htm?path=azathioprine-drug-information\" class=\"drug drug_general\">azathioprine</a>, <a href=\"topic.htm?path=cyclosporine-ciclosporin-drug-information\" class=\"drug drug_general\">cyclosporine</a>, or development of opportunistic infections after transplantation [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/15,18,19\" class=\"abstract_t\">15,18,19</a>].</p><p>In 20 to 50 percent of patients with peliosis hepatis, no risk factor is identified [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/5\" class=\"abstract_t\">5</a>].</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pathogenesis of peliosis hepatis is unclear, but probably involves hepatocellular necrosis and injury to the sinusoidal endothelium. One theory suggests that focal areas of hepatocellular necrosis destroy the reticulum framework thereby leading to central or peripheral hemorrhage [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/2\" class=\"abstract_t\">2</a>]. The area of necrosis can either heal or form a cyst, which can eventually develop an endothelial lining. This mechanism has been demonstrated in a mouse model where chemically-induced hepatocyte necrosis resulted in the development of peliotic changes [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/20,21\" class=\"abstract_t\">20,21</a>].</p><p>Direct endothelial cell injury may also have a role in the development of peliosis hepatis [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/8,22,23\" class=\"abstract_t\">8,22,23</a>]. An experimental study of cadmium toxicity in a rat model suggested that the initial damage to hepatocytes and sinusoidal cells leads to disruption of the sinusoidal endothelial cell lining followed by sinusoidal dilatation and ultimately formation of peliotic cavities [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/24-26\" class=\"abstract_t\">24-26</a>]. Studies involving electron microscopy of peliotic lesions from patients with AIDS have demonstrated <em>Bartonella</em> within sinusoidal epithelial cells, leading to microcirculatory damage [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/13,24\" class=\"abstract_t\">13,24</a>].</p><p>In addition, some patients with azathioprine-induced peliosis hepatis have evidence of sinusoidal injury [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/27\" class=\"abstract_t\">27</a>], while others have concomitant idiopathic noncirrhotic portal hypertension or veno-occlusive liver disease, both of which are known to be caused by drug-induced vascular injury [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/28\" class=\"abstract_t\">28</a>]. Other drugs known to cause sinusoidal endothelial cell damage include 6-thioguanine and urethane [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/25,27\" class=\"abstract_t\">25,27</a>]. Conversely, certain drugs (eg, anabolic steroids, glucocorticoids, <a href=\"topic.htm?path=methotrexate-drug-information\" class=\"drug drug_general\">methotrexate</a>, <a href=\"topic.htm?path=vitamin-a-drug-information\" class=\"drug drug_general\">vitamin A</a>, oral contraceptives) associated with peliosis hepatis do not cause sinusoidal endothelial cell injury and thus the mechanisms by which they lead to peliosis hepatis remain unclear [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/25\" class=\"abstract_t\">25</a>].</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h1\">CLINICAL FEATURES</span></p><p class=\"headingAnchor\" id=\"H2492127162\"><span class=\"h2\">Symptoms and signs</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The clinical presentation of peliosis is variable. Many patients are asymptomatic, and peliosis hepatis is discovered during the work up of abnormal liver function tests or incidentally on abdominal imaging [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/3\" class=\"abstract_t\">3</a>].</p><p>Some patients present with abdominal pain [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/29\" class=\"abstract_t\">29</a>], jaundice [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/30\" class=\"abstract_t\">30</a>], hepatomegaly [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/3,6\" class=\"abstract_t\">3,6</a>], portal hypertension [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/4,27,31,32\" class=\"abstract_t\">4,27,31,32</a>], or liver failure [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/27,33,34\" class=\"abstract_t\">27,33,34</a>]. Complications of portal hypertension are discussed separately. (See <a href=\"topic.htm?path=portal-hypertension-in-adults#H72827922\" class=\"medical medical_review\">&quot;Portal hypertension in adults&quot;, section on 'Clinical manifestations'</a>.)</p><p>Other patients present with ruptured or infarcted peliotic cysts resulting in significant and sometimes fatal intrahepatic or intraperitoneal hemorrhage [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/33,35-40\" class=\"abstract_t\">33,35-40</a>]. </p><p>The size of the peliotic cavities and extent of liver involvement are associated with the severity the clinical manifestations. Patients with minor microscopic forms of peliosis usually remain asymptomatic. Clinical manifestations are more common in patients with major or macroscopic forms of peliosis hepatis, characterized by large cysts that occupy a significant portion of the liver [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/3,11,18\" class=\"abstract_t\">3,11,18</a>]. One study of 12 patients with biopsy-confirmed peliosis hepatis reported hepatomegaly, portal hypertension, esophageal varices, and ascites in five out of six patients with major peliosis hepatis, while the other six patients with minor peliosis hepatis were asymptomatic [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/3\" class=\"abstract_t\">3</a>].</p><p>Bartonella-associated or bacillary peliosis hepatis may be associated with splenic peliosis and cutaneous bacillary angiomatosis [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/41,42\" class=\"abstract_t\">41,42</a>]. (See <a href=\"topic.htm?path=epidemiology-and-clinical-manifestations-of-bartonella-infections-in-hiv-infected-patients#H14119143\" class=\"medical medical_review\">&quot;Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients&quot;, section on 'Clinical manifestations'</a>.)</p><p class=\"headingAnchor\" id=\"H2294244160\"><span class=\"h2\">Laboratory findings</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Liver function tests may be abnormal but no specific cholestatic or hepatocellular pattern exists.</p><p class=\"headingAnchor\" id=\"H4014779005\"><span class=\"h2\">Imaging studies</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pattern of peliosis hepatis on various imaging modalities depends upon the pathologic type of the disease, size of the lesion, extent of communication with sinusoids, and presence of a thrombus or hemorrhage. </p><p>The microscopic (minor) form of peliosis hepatis tends to have no specific characteristics on imaging while the macroscopic (major) form of peliosis hepatis is characterized by large hepatic vascular lesions that can be visualized by various imaging techniques. Imaging studies may reveal a single lesion or multiple, diffuse lesions that appear infiltrating or that resemble abscesses (<a href=\"image.htm?imageKey=GAST%2F114287\" class=\"graphic graphic_diagnosticimage graphicRef114287 \">image 1</a>) [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/5,16,17,35,43\" class=\"abstract_t\">5,16,17,35,43</a>]. Specific imaging characteristics can help to differentiate these lesions from other space occupying structures [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/44,45\" class=\"abstract_t\">44,45</a>]. (See <a href=\"topic.htm?path=solid-liver-lesions-differential-diagnosis-and-evaluation\" class=\"medical medical_review\">&quot;Solid liver lesions: Differential diagnosis and evaluation&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>On ultrasound, lesions may appear as pseudocystic areas in the hepatic parenchyma. These lesions can be hypoechoic in an otherwise normal liver or they may appear hyperechoic in the setting of hepatic steatosis. Doppler studies can demonstrate the vascular nature of the lesion [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/5,46\" class=\"abstract_t\">5,46</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>On contrast-enhanced computed tomography (CT), the lesions can appear as heterogeneous densities that become hypodense on the late arterial and venous phase. Peripheral ring-like enhancement is occasionally seen. A characteristic finding is the absence of mass effect on the adjacent vasculature. In the case of hemorrhage, peliosis hepatis lesions appear as hyperattenuating structures on unenhanced CT [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/44,45\" class=\"abstract_t\">44,45</a>]. (See <a href=\"topic.htm?path=computed-tomography-of-the-hepatobiliary-tract\" class=\"medical medical_review\">&quot;Computed tomography of the hepatobiliary tract&quot;</a> and <a href=\"topic.htm?path=solid-liver-lesions-differential-diagnosis-and-evaluation#H155744958\" class=\"medical medical_review\">&quot;Solid liver lesions: Differential diagnosis and evaluation&quot;, section on 'Computed tomography'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>On magnetic resonance imaging (MRI), peliosis hepatis lesions are typically of low signal intensity on T1-weighted images and of high signal on T2-weighted images, with late and slow but intense enhancement on contrast-enhanced T1-weighted images. Fresh and actively circulating blood within the dilated sinusoids can cause hypervascular enhancement on the arterial phase of triphasic CT or MRI, whereas old and stagnated blood can lead to persistently low or slow enhancement on portal or delayed phase images [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/45,47,48\" class=\"abstract_t\">45,47,48</a>]. (See <a href=\"topic.htm?path=magnetic-resonance-imaging-of-the-hepatobiliary-tract\" class=\"medical medical_review\">&quot;Magnetic resonance imaging of the hepatobiliary tract&quot;</a> and <a href=\"topic.htm?path=solid-liver-lesions-differential-diagnosis-and-evaluation#H155744973\" class=\"medical medical_review\">&quot;Solid liver lesions: Differential diagnosis and evaluation&quot;, section on 'Magnetic resonance imaging'</a>.).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hepatic angiography of the lesions shows accumulation of contrast in the late arterial or parenchymal phase and retention of contrast through the early venous phase [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/35,44,49\" class=\"abstract_t\">35,44,49</a>]. Noninvasive diagnostic tests such as CT angiography are now preferred for the evaluation of hepatic lesions with vascular features.</p><p/><p class=\"headingAnchor\" id=\"H8\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of peliosis hepatis is suspected based on imaging findings particularly when an associated condition is present (eg, history of renal transplant or corticosteroid therapy). A definitive diagnosis of peliosis hepatis requires histologic examination acquired through liver biopsy [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/16,50\" class=\"abstract_t\">16,50</a>]. Patients with suspected bacillary peliosis may have skin lesions which can be biopsied, thereby avoiding a liver biopsy.</p><p>A definitive diagnosis is not always required. For patients with incidental imaging findings consistent with peliosis, it may be reasonable to defer biopsy which may be dangerous and to follow with serial imaging studies and liver function tests. (See <a href=\"#H3203497528\" class=\"local\">'Monitoring'</a> below.)</p><p>In contrast, when imaging findings suggest possible malignancy, a liver biopsy is indicated.</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Liver biopsy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>When a definitive diagnosis is required, histologic examination of liver tissue along with compatible clinical presentation and imaging findings establishes the diagnosis. </p><p>Successful percutaneous needle biopsies of a suspected peliotic lesion are described, but carry a significant risk of bleeding given the vascular nature of peliosis hepatis [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/51\" class=\"abstract_t\">51</a>]. In some case reports an intraoperative approach to liver biopsy with or without ultrasound guidance was used to reduce the risk of severe hemorrhage [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/5,52,53\" class=\"abstract_t\">5,52,53</a>]. Visualization of the liver surface at the time of surgery can also reveal findings suggestive of peliosis hepatis. </p><p class=\"headingAnchor\" id=\"H1404564448\"><span class=\"h2\">Pathologic findings</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Microscopic examination of peliosis hepatis reveals round or oval cavities that are randomly distributed between areas of normal hepatic parenchyma. The cavities communicate with sinusoids that are sometimes dilated. Dilation of space of Disse may be seen. Red blood cells can be seen in the peliotic cysts, dilated sinusoids, and space of Disse (<a href=\"image.htm?imageKey=GAST%2F74012%7EGAST%2F59203\" class=\"graphic graphic_picture graphicRef74012 graphicRef59203 \">picture 1A-B</a>) [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/4,54\" class=\"abstract_t\">4,54</a>].</p><p>Microscopically, there are two types of peliosis: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Parenchymal peliosis, characterized by cavities that are not lined by sinusoidal cells or fibrous tissue</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Phlebectatic peliosis, characterized by cavities that are lined by endothelium or fibrosis</p><p/><p>Both microscopic forms can be seen in the same liver and likely represent different stages of the disease [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/9\" class=\"abstract_t\">9</a>].</p><p>The microscopic appearance of peliosis hepatis may resemble secondary hepatic congestion due to sinusoidal obstruction syndrome (formerly known as hepatic veno-occlusive disease) or Budd-Chiari syndrome except that the lesions of peliosis hepatis are randomly distributed in the liver parenchyma while the other disorders are associated with sinusoidal dilation in the centrilobular areas (zone 3) [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/3\" class=\"abstract_t\">3</a>].</p><p>When bacillary peliosis is suspected (eg, in a patient with HIV), special diagnostic studies are ordered to identify the pathogen. (See <a href=\"topic.htm?path=diagnosis-treatment-and-prevention-of-bartonella-infections-in-hiv-infected-patients#H28105029\" class=\"medical medical_review\">&quot;Diagnosis, treatment, and prevention of Bartonella infections in HIV-infected patients&quot;, section on 'General background'</a>.).</p><p class=\"headingAnchor\" id=\"H2781444058\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The radiographic appearance of the hepatic vascular lesion is not specific for peliosis hepatis and alternative diagnoses should be considered. The differential diagnosis includes hypervascular tumors such as hepatocellular carcinoma and hepatic abscess [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/55\" class=\"abstract_t\">55</a>]. On imaging studies, the differential diagnosis includes other focal liver lesions including adenoma, hemangioma, focal nodular hyperplasia, abscess, hypervascular metastatic lesions, and hepatocellular carcinoma. When malignancy is suggested by imaging studies, a biopsy is usually performed and distinguishes tumor from peliosis. (See <a href=\"topic.htm?path=solid-liver-lesions-differential-diagnosis-and-evaluation\" class=\"medical medical_review\">&quot;Solid liver lesions: Differential diagnosis and evaluation&quot;</a>.) </p><p>As noted above, the differential diagnosis on microscopic examination of liver specimens includes sinusoidal obstruction syndrome, heart failure, and Budd-Chiari syndrome. The clinical setting (ie, bone marrow transplant) and findings on imaging studies (ie, hepatic vein thrombosis) can help distinguish among these entities. (See <a href=\"topic.htm?path=budd-chiari-syndrome-epidemiology-clinical-manifestations-and-diagnosis#H7\" class=\"medical medical_review\">&quot;Budd-Chiari syndrome: Epidemiology, clinical manifestations, and diagnosis&quot;, section on 'Diagnosis'</a> and <a href=\"topic.htm?path=diagnosis-of-hepatic-sinusoidal-obstruction-syndrome-veno-occlusive-disease-following-hematopoietic-cell-transplantation#H8039065\" class=\"medical medical_review\">&quot;Diagnosis of hepatic sinusoidal obstruction syndrome (veno-occlusive disease) following hematopoietic cell transplantation&quot;, section on 'Diagnosis'</a>.).</p><p class=\"headingAnchor\" id=\"H459143624\"><span class=\"h1\">TREATMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There is no specific treatment of peliosis hepatis except for the bacillary form. This is discussed separately. (See <a href=\"topic.htm?path=diagnosis-treatment-and-prevention-of-bartonella-infections-in-hiv-infected-patients#H28105064\" class=\"medical medical_review\">&quot;Diagnosis, treatment, and prevention of Bartonella infections in HIV-infected patients&quot;, section on 'Therapy'</a>.).</p><p class=\"headingAnchor\" id=\"H3203497528\"><span class=\"h2\">Monitoring</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There are no clear guidelines for monitoring patients with peliosis hepatis. We monitor liver function tests and obtain a repeat ultrasound every 12 months to ensure stability of the lesion. For larger lesions at risk for hemorrhage or rupture, we suggest monitoring with ultrasound on a more frequent basis than annually. </p><p class=\"headingAnchor\" id=\"H3606509135\"><span class=\"h2\">Treating associated condition</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Discontinuation of the causative agent or treatment of the underlying condition (<a href=\"image.htm?imageKey=GAST%2F66092\" class=\"graphic graphic_table graphicRef66092 \">table 1</a>) may result in regression of the hepatic lesions.</p><p>Case reports have documented regression of peliosis hepatis after discontinuation of an implicated drug [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/30,36,56\" class=\"abstract_t\">30,36,56</a>]. Such patients have had complete resolution of the clinical, laboratory, and radiographic abnormalities. By contrast, the disease tended to progress in patients in whom an implicated drug was continued [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/57,58\" class=\"abstract_t\">57,58</a>].</p><p>Bacillary peliosis hepatis responds to treatment with antibiotics, but untreated cases are associated with a high mortality rate. Hepatic lesions frequently recur even with the appropriate course of treatment [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/59\" class=\"abstract_t\">59</a>]. (See <a href=\"topic.htm?path=diagnosis-treatment-and-prevention-of-bartonella-infections-in-hiv-infected-patients#H28105064\" class=\"medical medical_review\">&quot;Diagnosis, treatment, and prevention of Bartonella infections in HIV-infected patients&quot;, section on 'Therapy'</a>.)</p><p class=\"headingAnchor\" id=\"H3251218797\"><span class=\"h2\">Managing complications</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>For patients whose lesions progress and are associated with moderate to severe symptoms or are judged to be at risk for rupture, surgical therapy can be considered [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/5,16,17\" class=\"abstract_t\">5,16,17</a>]. </p><p>Patients with portal hypertension should be managed similarly to those with portal hypertension caused by other conditions. (See <a href=\"topic.htm?path=portal-hypertension-in-adults#H72827698\" class=\"medical medical_review\">&quot;Portal hypertension in adults&quot;, section on 'Treatment'</a>.) </p><p>Portal hypertension in the setting of peliosis hepatis may be complicated by ascites, portopulmonary hypertension, or hepatopulmonary syndrome [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/31,34,60\" class=\"abstract_t\">31,34,60</a>]. (See <a href=\"topic.htm?path=portal-hypertension-in-adults#H72827922\" class=\"medical medical_review\">&quot;Portal hypertension in adults&quot;, section on 'Clinical manifestations'</a>.) </p><p>Rare cases of liver failure from peliosis hepatis have required liver transplantation [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/6,34\" class=\"abstract_t\">6,34</a>]. </p><p>Patients presenting with hepatic rupture or intraperitoneal hemorrhage due to peliosis hepatis have required emergent surgery for hepatic resection but successful angiographic intervention for transcatheter embolization has also been described [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/49,61\" class=\"abstract_t\">49,61</a>]. (See <a href=\"topic.htm?path=management-of-hepatic-trauma-in-adults#H631342355\" class=\"medical medical_review\">&quot;Management of hepatic trauma in adults&quot;, section on 'Hepatic embolization'</a>.)</p><p class=\"headingAnchor\" id=\"H52050050\"><span class=\"h1\">PROGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The natural history of peliosis hepatis is not well defined. There have been several outcomes described:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lesions discovered incidentally on imaging remain asymptomatic. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Peliosis hepatis may progress to complications including cholestasis, portal hypertension, liver failure, and hepatic rupture [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/33\" class=\"abstract_t\">33</a>]. Case reports have documented progression of disease in patients in whom an implicated drug was continued [<a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/57,58\" class=\"abstract_t\">57,58</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lesions regress after drug withdrawal or treatment of underlying infection.</p><p/><p class=\"headingAnchor\" id=\"H15\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Peliosis hepatis is a rare vascular condition of the liver characterized by the presence of cystic blood-filled cavities distributed randomly throughout the liver parenchyma. (See <a href=\"#H6\" class=\"local\">'Clinical features'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Peliosis hepatis has been associated with multiple drugs and chemicals, infections, hematologic disorders, malignancies, renal transplantation, HIV infection, and a variety of other conditions (<a href=\"image.htm?imageKey=GAST%2F66092\" class=\"graphic graphic_table graphicRef66092 \">table 1</a>). A bacillary form is caused by <em>Bartonella henselae</em>. An etiology remains unclear in 20 to 50 percent of patients. (See <a href=\"#H3\" class=\"local\">'Etiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Peliosis hepatis may be discovered incidentally during evaluation of abnormal liver function tests or on abdominal imaging. A subset of patients develops clinical features attributable to peliosis hepatis, which may include abdominal pain, jaundice, hepatomegaly, portal hypertension, liver failure, and rupture of the cyst with intraperitoneal hemorrhage. (See <a href=\"#H6\" class=\"local\">'Clinical features'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of peliosis hepatis requires a high degree of clinical suspicion. Various imaging modalities may help in establishing the diagnosis in the appropriate clinical setting. (See <a href=\"#H4014779005\" class=\"local\">'Imaging studies'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Liver biopsy of a peliotic lesion for histologic examination confirms the diagnosis, but percutaneous liver biopsy carries significant risk of hemorrhage due to the vascular nature of the lesion. Intraoperative liver biopsy may be a safer alternative if histologic confirmation is needed, particularly in the setting of a larger lesion at greater risk for hemorrhage. (See <a href=\"#H10\" class=\"local\">'Liver biopsy'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Withdrawal of the offending drug (ie, corticosteroids, oral contraceptives, <a href=\"topic.htm?path=azathioprine-drug-information\" class=\"drug drug_general\">azathioprine</a>) or treatment of the underlying condition may lead to regression of the liver lesions. (See <a href=\"#H459143624\" class=\"local\">'Treatment'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>There is no specific treatment for peliosis hepatis except for the bacillary form. (See <a href=\"topic.htm?path=diagnosis-treatment-and-prevention-of-bartonella-infections-in-hiv-infected-patients#H28105064\" class=\"medical medical_review\">&quot;Diagnosis, treatment, and prevention of Bartonella infections in HIV-infected patients&quot;, section on 'Therapy'</a>.)</p><p/><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/1\" class=\"nounderline abstract_t\">Biswas S, Rolain JM. Bartonella infection: treatment and drug resistance. Future Microbiol 2010; 5:1719.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/2\" class=\"nounderline abstract_t\">ZAK FG. Peliosis hepatis. Am J Pathol 1950; 26:1.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/3\" class=\"nounderline abstract_t\">Degott C, Rueff B, Kreis H, et al. Peliosis hepatis in recipients of renal transplants. Gut 1978; 19:748.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/4\" class=\"nounderline abstract_t\">Zafrani ES, Cazier A, Baudelot AM, Feldmann G. Ultrastructural lesions of the liver in human peliosis. A report of 12 cases. Am J Pathol 1984; 114:349.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/5\" class=\"nounderline abstract_t\">Crocetti D, Palmieri A, Pedull&agrave; G, et al. Peliosis hepatis: Personal experience and literature review. World J Gastroenterol 2015; 21:13188.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/6\" class=\"nounderline abstract_t\">Atila K, Coker A, U&ccedil;ar D, et al. A rare clinical entity misdiagnosed as a tumor: peliosis hepatis. Ulus Travma Acil Cerrahi Derg 2007; 13:149.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/7\" class=\"nounderline abstract_t\">Izumi S, Nishiuchi M, Kameda Y, et al. Laparoscopic study of peliosis hepatis and nodular transformation of the liver before and after renal transplantation: natural history and aetiology in follow-up cases. J Hepatol 1994; 20:129.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/8\" class=\"nounderline abstract_t\">Zafrani ES, von Pinaudeau Y, Dhumeaux D. Drug-induced vascular lesions of the liver. Arch Intern Med 1983; 143:495.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/9\" class=\"nounderline abstract_t\">YANOFF M, RAWSON AJ. PELIOSIS HEPATIS. AN ANATOMIC STUDY WITH DEMONSTRATION OF TWO VARIETIES. Arch Pathol 1964; 77:159.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/10\" class=\"nounderline abstract_t\">Wakabayashi T, Onda H, Tada T, et al. High incidence of peliosis hepatis in autopsy cases of aplastic anemia with special reference to anabolic steroid therapy. Acta Pathol Jpn 1984; 34:1079.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/11\" class=\"nounderline abstract_t\">Degos F, Degott C, Bedrossian J, et al. Is renal transplantation involved in post-transplantation liver disease? A prospective study. Transplantation 1980; 29:100.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/12\" class=\"nounderline abstract_t\">Chopra S, Edelstein A, Koff RS, et al. Peliosis hepatis in hematologic disease. Report of two cases. JAMA 1978; 240:1153.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/13\" class=\"nounderline abstract_t\">Scoazec JY, Marche C, Girard PM, et al. Peliosis hepatis and sinusoidal dilation during infection by the human immunodeficiency virus (HIV). An ultrastructural study. Am J Pathol 1988; 131:38.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/14\" class=\"nounderline abstract_t\">Matsumoto T, Yoshimine T, Shimouchi K, et al. The liver in systemic lupus erythematosus: pathologic analysis of 52 cases and review of Japanese Autopsy Registry Data. Hum Pathol 1992; 23:1151.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/15\" class=\"nounderline abstract_t\">Ahsan N, Holman MJ, Riley TR, et al. Peloisis hepatis due to Bartonella henselae in transplantation: a hemato-hepato-renal syndrome. Transplantation 1998; 65:1000.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/16\" class=\"nounderline abstract_t\">Xiong WJ, Hu LJ, Jian YC, et al. Focal peliosis hepatis in a colon cancer patient resembling metastatic liver tumor. World J Gastroenterol 2012; 18:5999.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/17\" class=\"nounderline abstract_t\">Pan W, Hong HJ, Chen YL, et al. Surgical treatment of a patient with peliosis hepatis: a case report. World J Gastroenterol 2013; 19:2578.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/18\" class=\"nounderline abstract_t\">Cavalcanti R, Pol S, Carnot F, et al. Impact and evolution of peliosis hepatis in renal transplant recipients. Transplantation 1994; 58:315.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/19\" class=\"nounderline abstract_t\">Ahsan N, Rao KV. Hepatobiliary diseases after kidney transplantation unrelated to classic hepatitis virus. Semin Dial 2002; 15:358.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/20\" class=\"nounderline abstract_t\">Bagheri SA, Boyer JL. Peliosis hepatis associated with androgenic-anabolic steroid therapy. A severe form of hepatic injury. Ann Intern Med 1974; 81:610.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/21\" class=\"nounderline abstract_t\">Ruebner BH, Watanabe K, Wand JS. Lytic necrosis resembling peliosis hepatis produced by lasiocarpine in the mouse liver. A light and electron microscopic study. Am J Pathol 1970; 60:247.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/22\" class=\"nounderline abstract_t\">Zafrani ES, Feldmann G. [Does a characteristic hepatic sinusoid pathology exist?]. Gastroenterol Clin Biol 1986; 10:105.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/23\" class=\"nounderline abstract_t\">Zafrani ES, Bernuau D, Feldmann G. Peliosis-like ultrastructural changes of the hepatic sinusoids in human chronic hypervitaminosis A: report of three cases. Hum Pathol 1984; 15:1166.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/24\" class=\"nounderline abstract_t\">Leong SS, Cazen RA, Yu GS, et al. Abdominal visceral peliosis associated with bacillary angiomatosis. Ultrastructural evidence of endothelial destruction by bacilli. Arch Pathol Lab Med 1992; 116:866.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/25\" class=\"nounderline abstract_t\">DeLeve LD. Hepatic microvasculature in liver injury. Semin Liver Dis 2007; 27:390.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/26\" class=\"nounderline abstract_t\">Tzirogiannis KN, Papadimas GK, Kondyli VG, et al. Peliosis hepatis: microscopic and macroscopic type, time pattern, and correlation with liver cell apoptosis in a model of toxic liver injury. Dig Dis Sci 2006; 51:1998.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/27\" class=\"nounderline abstract_t\">Haboubi NY, Ali HH, Whitwell HL, Ackrill P. Role of endothelial cell injury in the spectrum of azathioprine-induced liver disease after renal transplant: light microscopy and ultrastructural observations. Am J Gastroenterol 1988; 83:256.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/28\" class=\"nounderline abstract_t\">Buffet C, Cantarovitch M, Pelletier G, et al. Three cases of nodular regenerative hyperplasia of the liver following renal transplantation. Nephrol Dial Transplant 1988; 3:327.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/29\" class=\"nounderline abstract_t\">Hung NR, Chantrain L, Dechambre S. Peliosis hepatis revealed by biliary colic in a patient with oral contraceptive use. Acta Chir Belg 2004; 104:727.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/30\" class=\"nounderline abstract_t\">Simon DM, Krause R, Galambos JT. Peliosis hepatis in a patient with marasmus. Gastroenterology 1988; 95:805.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/31\" class=\"nounderline abstract_t\">Berzigotti A, Magalotti D, Zappoli P, et al. Peliosis hepatis as an early histological finding in idiopathic portal hypertension: A case report. World J Gastroenterol 2006; 12:3612.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/32\" class=\"nounderline abstract_t\">Chawla SK, Patel HD, Mahadevia SD, LoPresti PA. Portal hypertension in peliosis hepatis. Report of the first case. Am J Proctol Gastroenterol Colon Rectal Surg 1980; 31:11.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/33\" class=\"nounderline abstract_t\">Choi SK, Jin JS, Cho SG, et al. Spontaneous liver rupture in a patient with peliosis hepatis: a case report. World J Gastroenterol 2009; 15:5493.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/34\" class=\"nounderline abstract_t\">Hyodo M, Mogensen AM, Larsen PN, et al. Idiopathic extensive peliosis hepatis treated with liver transplantation. J Hepatobiliary Pancreat Surg 2004; 11:371.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/35\" class=\"nounderline abstract_t\">Kim EA, Yoon KH, Jeon SJ, et al. Peliosis hepatis with hemorrhagic necrosis and rupture: a case report with emphasis on the multi-detector CT findings. Korean J Radiol 2007; 8:64.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/36\" class=\"nounderline abstract_t\">Khadilkar UN, Prabhu S, Sharma D. Peliosis hepatis presenting as hemoperitoneum. Indian J Med Sci 2008; 62:236.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/37\" class=\"nounderline abstract_t\">Mar&eacute;chal R, Taccone FS, Bourgeois N, Hittelet A. [Spontaneous intrahepatic haemorrhage due to peliosis hepatis]. Rev Med Brux 2005; 26:451.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/38\" class=\"nounderline abstract_t\">Hayward SR, Lucas CE, Ledgerwood AM. Recurrent spontaneous intrahepatic hemorrhage from peliosis hepatis. Arch Surg 1991; 126:782.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/39\" class=\"nounderline abstract_t\">Wang SY, Ruggles S, Vade A, et al. Hepatic rupture caused by peliosis hepatis. J Pediatr Surg 2001; 36:1456.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/40\" class=\"nounderline abstract_t\">Lozano F, Corzo JE, Le&oacute;n EM, et al. Massive hemoperitoneum: a new manifestation of bacillary peliosis in human immunodeficiency virus infection. Clin Infect Dis 1999; 28:911.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/41\" class=\"nounderline abstract_t\">Plettenberg A, Lorenzen T, Burtsche BT, et al. Bacillary angiomatosis in HIV-infected patients--an epidemiological and clinical study. Dermatology 2000; 201:326.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/42\" class=\"nounderline abstract_t\">Radin DR, Kanel GC. Peliosis hepatis in a patient with human immunodeficiency virus infection. AJR Am J Roentgenol 1991; 156:91.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/43\" class=\"nounderline abstract_t\">Chen JF, Chen WX, Zhang HY, Zhang WY. Peliosis and gummatous syphilis of the liver: a case report. World J Gastroenterol 2008; 14:1961.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/44\" class=\"nounderline abstract_t\">Iannaccone R, Federle MP, Brancatelli G, et al. Peliosis hepatis: spectrum of imaging findings. AJR Am J Roentgenol 2006; 187:W43.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/45\" class=\"nounderline abstract_t\">Kim SH, Lee JM, Kim WH, et al. Focal peliosis hepatis as a mimicker of hepatic tumors: radiological-pathological correlation. J Comput Assist Tomogr 2007; 31:79.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/46\" class=\"nounderline abstract_t\">Xu HX, Xie XY, Lu MD, et al. Unusual benign focal liver lesions: findings on real-time contrast-enhanced sonography. J Ultrasound Med 2008; 27:243.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/47\" class=\"nounderline abstract_t\">Yekeler E, Dursun M, Tunaci A, et al. Diagnosing of peliosis hepatis by magnetic resonance imaging. J Hepatol 2004; 41:351.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/48\" class=\"nounderline abstract_t\">Steinke K, Terraciano L, Wiesner W. Unusual cross-sectional imaging findings in hepatic peliosis. Eur Radiol 2003; 13:1916.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/49\" class=\"nounderline abstract_t\">O&#341;iordan K, Blei A, Vogelzang R, et al. Peliosis hepatis with intrahepatic hemorrhage: successful embolization of the hepatic artery. HPB Surg 2000; 11:353.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/50\" class=\"nounderline abstract_t\">Battal B, Kocaoglu M, Atay AA, Bulakbasi N. Multifocal peliosis hepatis: MR and diffusion-weighted MR-imaging findings of an atypical case. Ups J Med Sci 2010; 115:153.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/51\" class=\"nounderline abstract_t\">Kim SB, Kim DK, Byun SJ, et al. Peliosis hepatis presenting with massive hepatomegaly in a patient with idiopathic thrombocytopenic purpura. Clin Mol Hepatol 2015; 21:387.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/52\" class=\"nounderline abstract_t\">Kleger A, Bommer M, Kunze M, et al. First reported case of disease: peliosis hepatis as cardinal symptom of Hodgkin's lymphoma. Oncologist 2009; 14:1088.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/53\" class=\"nounderline abstract_t\">Dai W, Zhong D. Peliosis hepatis mimicking cancer: A case report. Oncol Lett 2013; 6:960.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/54\" class=\"nounderline abstract_t\">Iwai M, Muramatsu A, Tanaka S, et al. Macroscopic and microscopic findings of livers in malignant hematologic disorders, biopsied under peritoneoscopy. J Clin Gastroenterol 2002; 35:262.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/55\" class=\"nounderline abstract_t\">Cohen GS, Ball DS, Boyd-Kranis R, et al. Peliosis hepatis mimicking hepatic abscess: fatal outcome following percutaneous drainage. J Vasc Interv Radiol 1994; 5:643.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/56\" class=\"nounderline abstract_t\">Abdelli N, Bouhnik Y, Lavergne-Slove A, et al. [Peliosis hepatitis during intestinal lymphomatous polyposis treated with chemotherapy and radiotherapy. Regression after antibiotic therapy]. Gastroenterol Clin Biol 1995; 19:537.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/57\" class=\"nounderline abstract_t\">Testa G, Panaro F, Sankary H, et al. Peliosis hepatis in a living related liver transplantation donor candidate. J Gastroenterol Hepatol 2006; 21:1075.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/58\" class=\"nounderline abstract_t\">Adler M, Delhaye M, Deprez C, et al. Hepatic vascular disease after kidney transplantation: report of two cases and review of the literature. Nephrol Dial Transplant 1987; 2:183.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/59\" class=\"nounderline abstract_t\">Rolain JM, Brouqui P, Koehler JE, et al. Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother 2004; 48:1921.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/60\" class=\"nounderline abstract_t\">Kallel L, Matri S, Karoui S, et al. [Idiopathic peliosis hepatis complicated by a hepatopulmonary syndrome]. Gastroenterol Clin Biol 2008; 32:88.</a></li><li><a href=\"https://www.uptodate.com/contents/peliosis-hepatis/abstract/61\" class=\"nounderline abstract_t\">Cimbanassi S, Aseni P, Mariani A, et al. Spontaneous hepatic rupture during pregnancy in a patient with peliosis hepatis. Ann Hepatol 2015; 14:553.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 3603 Version 15.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H15\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">EPIDEMIOLOGY</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">ETIOLOGY</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">PATHOGENESIS</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">CLINICAL FEATURES</a><ul><li><a href=\"#H2492127162\" id=\"outline-link-H2492127162\">Symptoms and signs</a></li><li><a href=\"#H2294244160\" id=\"outline-link-H2294244160\">Laboratory findings</a></li><li><a href=\"#H4014779005\" id=\"outline-link-H4014779005\">Imaging studies</a></li></ul></li><li><a href=\"#H8\" id=\"outline-link-H8\">DIAGNOSIS</a><ul><li><a href=\"#H10\" id=\"outline-link-H10\">Liver biopsy</a></li><li><a href=\"#H1404564448\" id=\"outline-link-H1404564448\">Pathologic findings</a></li></ul></li><li><a href=\"#H2781444058\" id=\"outline-link-H2781444058\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H459143624\" id=\"outline-link-H459143624\">TREATMENT</a><ul><li><a href=\"#H3203497528\" id=\"outline-link-H3203497528\">Monitoring</a></li><li><a href=\"#H3606509135\" id=\"outline-link-H3606509135\">Treating associated condition</a></li><li><a href=\"#H3251218797\" id=\"outline-link-H3251218797\">Managing complications</a></li></ul></li><li><a href=\"#H52050050\" id=\"outline-link-H52050050\">PROGNOSIS</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"GAST/3603|DiagnosticImage\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"DIAGNOSTIC IMAGES\">DIAGNOSTIC IMAGES</a></div><ul><li><a href=\"image.htm?imageKey=GAST/114287\" class=\"graphic graphic_diagnosticimage\">- Peliosis hepatis CT image</a></li></ul></li><li><div id=\"GAST/3603|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=GAST/74012\" class=\"graphic graphic_picture\">- Peliosis hepatis low power</a></li><li><a href=\"image.htm?imageKey=GAST/59203\" class=\"graphic graphic_picture\">- Peliosis hepatis high power</a></li></ul></li><li><div id=\"GAST/3603|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=GAST/66092\" class=\"graphic graphic_table\">- Conditions peliosis hepatis</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=budd-chiari-syndrome-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Budd-Chiari syndrome: Epidemiology, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=computed-tomography-of-the-hepatobiliary-tract\" class=\"medical medical_review\">Computed tomography of the hepatobiliary tract</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-of-hepatic-sinusoidal-obstruction-syndrome-veno-occlusive-disease-following-hematopoietic-cell-transplantation\" class=\"medical medical_review\">Diagnosis of hepatic sinusoidal obstruction syndrome (veno-occlusive disease) following hematopoietic cell transplantation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-treatment-and-prevention-of-bartonella-infections-in-hiv-infected-patients\" class=\"medical medical_review\">Diagnosis, treatment, and prevention of Bartonella infections in HIV-infected patients</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-and-clinical-manifestations-of-bartonella-infections-in-hiv-infected-patients\" class=\"medical medical_review\">Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=magnetic-resonance-imaging-of-the-hepatobiliary-tract\" class=\"medical medical_review\">Magnetic resonance imaging of the hepatobiliary tract</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-hepatic-trauma-in-adults\" class=\"medical medical_review\">Management of hepatic trauma in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=portal-hypertension-in-adults\" class=\"medical medical_review\">Portal hypertension in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=solid-liver-lesions-differential-diagnosis-and-evaluation\" class=\"medical medical_review\">Solid liver lesions: Differential diagnosis and evaluation</a></li></ul></div></div>","javascript":null}